Frankel Lexi, Ardeljan Amalia D, Rashid Ali, Nair Abhishek, Takabe Kazuaki, Rashid Omar M
Department of Surgery, Michael and Dianne Biennes Comprehensive Cancer Center, Holy Cross Health, Fort Lauderdale, FL, USA.
Nova Southeastern University, Dr. Kiran C. Patel College of Allopathic Medicine, Fort Lauderdale, FL, USA.
World J Oncol. 2023 Oct;14(5):401-405. doi: 10.14740/wjon1580. Epub 2023 Sep 20.
Enhanced recovery protocols (ERPs) have been shown to improve the outcomes of gastrointestinal cancer care, leading to reduced morbidity of gastrointestinal treatment and reduced delays in systemic therapy. ERP implementation has also previously shown a reduction in length of stay (LOS) without changing the readmission rate; however, the economic cost associated with these measures has not yet been quantified. The aim of this study was to evaluate the economic costs of ERP implementation for colorectal cancer at a community hospital.
The Diagnostic Related Group (DRG) codes were used to assess costs associated with the hospitalizations of cases in the ERP versus non-ERP groups. The American Hospital Association (AHA) Annual Survey from 1999 to 2015 was used to provide the expenses per day for inpatient hospitalization in the United States. Postoperative LOS, average healthcare costs, and postoperative complications between ERP-protocol and non-ERP protocol groups were analyzed using analysis of variance (ANOVA) and independent -tests.
The AHA survey estimated that $2,265 was incurred per day for non-profit hospitals in Florida and $2,346 was incurred per day for the United States. For all DRG codes, the ERP-participating group was associated with a shorter LOS and reduced health care costs. LOS-associated cost was compared between ERP and non-ERP groups: for DRG 329, the total savings was $162,118.8 (n = 12 non-ERP versus n = 8 ERP, P = 4.39 × 10); for DRG 330, $314,552.64 (n = 36 non-ERP versus n = 24 ERP, P = 2.72 × 10); and for DRG 331, $89,302.73 (n = 11 non-ERP versus n = 23 for ERP, P = 4.19 × 10).
The implementation of an ERP protocol for colorectal cancer was associated with significantly reduced costs in a community hospital.
强化康复方案(ERPs)已被证明可改善胃肠道癌症护理的结果,降低胃肠道治疗的发病率,并减少全身治疗的延迟。此前ERP的实施还显示住院时间(LOS)缩短,而再入院率未变;然而,与这些措施相关的经济成本尚未量化。本研究的目的是评估社区医院实施ERP用于结直肠癌的经济成本。
使用诊断相关组(DRG)编码来评估ERP组与非ERP组病例住院相关的成本。利用1999年至2015年美国医院协会(AHA)年度调查提供美国住院患者每日费用。采用方差分析(ANOVA)和独立检验分析ERP方案组与非ERP方案组之间的术后住院时间、平均医疗费用和术后并发症。
AHA调查估计,佛罗里达州非营利性医院每日费用为2265美元,美国为每日2346美元。对于所有DRG编码,参与ERP的组住院时间较短且医疗费用降低。比较了ERP组和非ERP组与住院时间相关的成本:对于DRG 329,总节省为162118.8美元(非ERP组n = 12,ERP组n = 8,P = 4.39×10);对于DRG 330,为314552.64美元(非ERP组n = 36,ERP组n = 24,P = 2.72×10);对于DRG 331,为89302.73美元(非ERP组n = 11,ERP组n = 23,P = 4.19×10)。
社区医院实施结直肠癌ERP方案可显著降低成本。